Roivant Sciences Ltd. Ratios

Ratios Mar2021 Dec2021 Mar2022 Dec2022 Mar2023 Dec2023 Mar2024 Dec2024 Mar2025
Profitability
Gross Margin 91.36%83.78%90.38%95.11%96.86%
EBT Margin -3,776.20%-1,670.85%-2,806.82%13,963.43%-2,346.02%
EBIT Margin -4,500.52%-2,444.82%-2,875.87%13,746.93%-3,453.32%
EBITDA Margin -4,500.52%-2,444.82%-2,875.87%13,746.93%-3,453.32%
Operating Margin -4,500.52%-2,444.82%-2,875.87%13,746.93%-3,453.32%
Net Margin -3,783.29%-1,671.52%-718.02%-963.37%1,284.50%
FCF Margin -2,344.80%-1,257.40%-2,715.14%-2,343.56%-2,905.21%
Efficiency
Inventory Average 4.00M20.25M
Assets Average 2,694.53M2,692.25M2,394.04M2,296.28M4,851.14M7,267.58M6,507.41M5,614.64M
Equity Average 2,143.39M2,143.10M1,733.04M1,517.36M4,096.08M6,516.56M5,992.25M5,361.58M
Invested Capital 2,209.79M2,451.30M2,248.97M1,802.26M1,983.10M6,987.92M6,879.12M5,535.97M5,187.20M
Asset Utilization Ratio 0.270.020.360.010.200.000.170.01
Leverage & Solvency
Interest Coverage Ratio -191.97-32.42129.31
Debt to Equity 0.080.090.020.140.120.030.03
Debt Ratio 0.070.070.010.090.080.030.03
Equity Ratio 0.790.800.790.650.670.900.890.960.95
Times Interest Earned -191.97-32.42129.31
Valuation
Enterprise Value -1388.92M5,067.02M1,736.53M4,740.28M4,365.19M2,822.86M2,478.61M3,811.64M2,812.42M
Market Capitalization 502.10M6,902.67M3,418.84M5,796.10M5,597.19M9,028.04M8,493.62M8,611.65M7,199.71M
Return Ratios
Return on Sales -37.83%-16.72%-7.18%-9.63%12.84%
Return on Capital Employed -0.54%-0.45%0.64%-0.18%
Return on Invested Capital 0.65%
Return on Assets -0.34%-0.10%-0.04%0.07%
Return on Equity -0.43%-0.15%-0.05%0.07%